| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1042153574 |
| P356 | DOI | 10.2165/00019053-200624010-00001 |
| P698 | PubMed publication ID | 16445299 |
| P50 | author | Mark Sculpher | Q91668374 |
| Keith R. Abrams | Q51913713 | ||
| P2093 | author name string | Guobing Lu | |
| A E Ades | |||
| Alex Sutton | |||
| Nicola Cooper | |||
| Nicky Welton | |||
| P2860 | cites work | Net health benefits: a new framework for the analysis of uncertainty in cost-effectiveness analysis | Q74496928 |
| When are observational studies as credible as randomised trials? | Q80122032 | ||
| Assessing generalisability by location in trial-based cost-effectiveness analysis: the use of multilevel models | Q80603253 | ||
| Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients | Q24555072 | ||
| Randomized, controlled trials, observational studies, and the hierarchy of research designs | Q24670544 | ||
| Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials | Q27860735 | ||
| Meta-analysis in clinical trials | Q27860779 | ||
| Combination of direct and indirect evidence in mixed treatment comparisons | Q29619499 | ||
| Performing cost-effectiveness analysis by integrating randomized trial data with a comprehensive decision model: application to treatment of acute ischemic stroke | Q30573387 | ||
| A comparison of summary patient-level covariates in meta-regression with individual patient data meta-analysis | Q30669346 | ||
| Surrogate end points, health outcomes, and the drug-approval process for the treatment of risk factors for cardiovascular disease | Q33872281 | ||
| A comparison of observational studies and randomized, controlled trials | Q33906423 | ||
| Bayesian methods in meta-analysis and evidence synthesis | Q34329700 | ||
| Health economic guidelines--similarities, differences and some implications | Q34436165 | ||
| Decision analytical economic modelling within a Bayesian framework: application to prophylactic antibiotics use for caesarean section. | Q35040678 | ||
| Clinical efficacy of antiretroviral combination therapy based on protease inhibitors or non-nucleoside analogue reverse transcriptase inhibitors: indirect comparison of controlled trials | Q35629103 | ||
| Comprehensive decision analytical modelling in economic evaluation: a Bayesian approach | Q35674633 | ||
| The use of modelling to evaluate new drugs for patients with a chronic condition: the case of antibodies against tumour necrosis factor in rheumatoid arthritis | Q35675008 | ||
| Overestimation of complication rates in evaluations of Chlamydia trachomatis screening programmes--implications for cost-effectiveness analyses | Q35745062 | ||
| A rapid and systematic review and economic evaluation of the clinical and cost-effectiveness of newer drugs for treatment of mania associated with bipolar affective disorder | Q35775412 | ||
| A perspective on surrogate endpoints in controlled clinical trials | Q35805910 | ||
| Percutaneous transluminal coronary angioplasty versus medical treatment for non-acute coronary heart disease: meta-analysis of randomised controlled trials | Q38630711 | ||
| Choosing between randomised and non-randomised studies: a systematic review | Q38921696 | ||
| Validity of indirect comparison for estimating efficacy of competing interventions: empirical evidence from published meta-analyses | Q39735046 | ||
| Assessing apparent treatment--covariate interactions in randomized clinical trials | Q39863059 | ||
| Meta-analytic tools for medical decision making: a practical guide | Q40616355 | ||
| A rational framework for decision making by the National Institute For Clinical Excellence (NICE). | Q40632683 | ||
| Hierarchical models in generalized synthesis of evidence: an example based on studies of breast cancer screening | Q40734392 | ||
| Surrogate end points in clinical trials: are we being misled? | Q41117631 | ||
| Surrogate endpoints in clinical trials: definition and operational criteria | Q41310696 | ||
| Generalized synthesis of evidence and the threat of dissemination bias. the example of electronic fetal heart rate monitoring (EFM). | Q43508915 | ||
| Probabilistic analysis of cost-effectiveness models: choosing between treatment strategies for gastroesophageal reflux disease | Q44084354 | ||
| How vague is vague? A simulation study of the impact of the use of vague prior distributions in MCMC using WinBUGS. | Q44569346 | ||
| Economic Analysis Alongside Clinical Trials: Revisiting the Methodological Issues | Q46686334 | ||
| Bayesian approaches to multiple sources of evidence and uncertainty in complex cost-effectiveness modelling | Q47345641 | ||
| A chain of evidence with mixed comparisons: models for multi-parameter synthesis and consistency of evidence | Q47626233 | ||
| On meta-analytic assessment of surrogate outcomes. | Q47671594 | ||
| Multivariate meta-analysis | Q47768922 | ||
| Markov chain Monte Carlo estimation of a multiparameter decision model: consistency of evidence and the accurate assessment of uncertainty. | Q52035592 | ||
| Bayesian cost-effectiveness analysis. An example using the GUSTO trial. | Q52064635 | ||
| Analysing the relationship between treatment effect and underlying risk in meta-analysis: comparison and development of approaches. | Q52070121 | ||
| A Bayesian approach to modelling the natural history of a chronic condition from observations with intervention. | Q52209683 | ||
| A Bayesian approach to sensitivity analysis. | Q52213529 | ||
| Meta-analysis for the evaluation of potential surrogate markers. | Q52256112 | ||
| Borrowing strength from external trials in a meta-analysis. | Q52287071 | ||
| Bayesian subset analysis in a colorectal cancer clinical trial | Q52427219 | ||
| Bayesian Subset Analysis | Q52443582 | ||
| Inter-study differences: how should they influence the interpretation and analysis of results? | Q52599205 | ||
| A new form of meta-analysis for combining results from randomized clinical trials and medical-practice databases. | Q52885014 | ||
| Meta-analysis of multiple outcomes by regression with random effects. | Q52906847 | ||
| Management of non-ST-elevation acute coronary syndromes: how cost-effective are glycoprotein IIb/IIIA antagonists in the UK National Health Service? | Q56458776 | ||
| Probabilistic analysis of decision trees using Monte Carlo simulation | Q69497102 | ||
| Probabilistic sensitivity analysis using Monte Carlo simulation. A practical approach | Q69788749 | ||
| Multiple-outcome meta-analysis of clinical trials | Q71156715 | ||
| Health outcomes associated with calcium antagonists compared with other first-line antihypertensive therapies: a meta-analysis of randomised controlled trials | Q73328473 | ||
| Meta-analysis of multitreatment studies | Q74143893 | ||
| P433 | issue | 1 | |
| P921 | main subject | cost-effectiveness analysis | Q1754768 |
| P304 | page(s) | 1-19 | |
| P577 | publication date | 2006-01-01 | |
| P1433 | published in | PharmacoEconomics | Q7180778 |
| P1476 | title | Bayesian methods for evidence synthesis in cost-effectiveness analysis | |
| P478 | volume | 24 |
| Q37337402 | 'Arm-based' parameterization for network meta-analysis |
| Q33261643 | 'Lost in translation': accounting for between-country differences in the analysis of multinational cost-effectiveness data |
| Q37354981 | A Bayesian micro-simulation to evaluate the cost-effectiveness of interventions for mastitis control during the dry period in UK dairy herds |
| Q44722340 | A Bayesian network meta-analysis for binary outcome: how to do it. |
| Q44628538 | A choice that matters? Smulation study on the impact of direct meta-analysis methods on health economic outcomes. |
| Q38749925 | A mixed treatment comparison to compare the efficacy and safety of botulinum toxin treatments for cervical dystonia |
| Q37745944 | A network meta-analysis of eight chemotherapy regimens for treatment of advanced ovarian cancer |
| Q35778052 | A network meta-analysis of the efficacy and side effects of UDCA-based therapies for primary sclerosing cholangitis. |
| Q35180653 | A network meta-analysis of the relative efficacy of treatments for actinic keratosis of the face or scalp in Europe |
| Q50110124 | A network meta-analysis on comparative efficacy and all-cause discontinuation of antimanic treatments in acute bipolar mania |
| Q41897242 | A primer on network meta-analysis for dental research |
| Q48698887 | A taxonomy of model structures for economic evaluation of health technologies |
| Q58604122 | Acupuncture and Related Therapies for Obesity: A Network Meta-Analysis |
| Q38137541 | Adjuvant treatments for resected pancreatic adenocarcinoma: a systematic review and network meta-analysis |
| Q41015461 | An Efficient Estimator for the Expected Value of Sample Information |
| Q36776918 | An Italian cost-effectiveness analysis of paclitaxel albumin (nab-paclitaxel) versus conventional paclitaxel for metastatic breast cancer patients: the COSTANza study |
| Q40956038 | An alternative parameterization of Bayesian logistic hierarchical models for mixed treatment comparisons |
| Q26827222 | An overview of conducting systematic reviews with network meta-analysis |
| Q36635503 | Analysis sans frontières: can we ever make economic evaluations generalisable across jurisdictions? |
| Q38257483 | Autism research funding allocation: can economics tell us if we have got it right? |
| Q38936428 | Bayesian Methods for Calibrating Health Policy Models: A Tutorial |
| Q33493047 | Bayesian hierarchical models for cost-effectiveness analyses that use data from cluster randomized trials |
| Q37565126 | Bayesian network meta-analysis comparing five contemporary treatment strategies for newly diagnosed acute promyelocytic leukaemia |
| Q38662083 | Bayesian one-step IPD network meta-analysis of time-to-event data using Royston-Parmar models. |
| Q82477098 | Better analysis for better decisions: has pharmacoeconomics come of age? |
| Q47420701 | Bevacizumab in combination with different platinum-based doublets in the first-line treatment for advanced nonsquamous non-small-cell lung cancer: A network meta-analysis. |
| Q111441940 | CaliPro: A Calibration Protocol That Utilizes Parameter Density Estimation to Explore Parameter Space and Calibrate Complex Biological Models |
| Q36103185 | Combined resynchronisation and implantable defibrillator therapy in left ventricular dysfunction: Bayesian network meta-analysis of randomised controlled trials |
| Q38987093 | Comparative Effectiveness of Mesalamine, Sulfasalazine, Corticosteroids, and Budesonide for the Induction of Remission in Crohn's Disease: A Bayesian Network Meta-analysis |
| Q57074422 | Comparative Effectiveness of Prophylactic Therapies for Necrotizing Enterocolitis in Preterm Infants: Protocol for a Network Meta-analysis of Randomized Trials |
| Q55484735 | Comparative Efficacy and Safety of Therapies in IgA Nephropathy: A Network Meta-analysis of Randomized Controlled Trials. |
| Q33812681 | Comparative effectiveness of 9 ovulation-induction therapies in patients with clomiphene citrate-resistant polycystic ovary syndrome: a network meta-analysis. |
| Q35123017 | Comparative effectiveness of different forms of telemedicine for individuals with heart failure (HF): a systematic review and network meta-analysis |
| Q36354602 | Comparative effectiveness of glycemic control in patients with type 2 diabetes treated with GLP-1 receptor agonists: a network meta-analysis of placebo-controlled and active-comparator trials |
| Q61801321 | Comparative effectiveness of the different components of care provided in heart failure clinics-protocol for a systematic review and network meta-analysis |
| Q29619093 | Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis |
| Q38642339 | Comparative efficacy and acceptability of antidepressant treatment in poststroke depression: a multiple-treatments meta-analysis |
| Q35009609 | Comparative efficacy and acceptability of antidepressants in Parkinson's disease: a network meta-analysis |
| Q28245879 | Comparative efficacy and acceptability of antimanic drugs in acute mania: a multiple-treatments meta-analysis |
| Q47134431 | Comparative efficacy and safety of antibiotics used to treat acute bacterial skin and skin structure infections: Results of a network meta-analysis |
| Q26828622 | Comparative efficacy and safety of biosimilar infliximab and other biological treatments in ankylosing spondylitis: systematic literature review and meta-analysis |
| Q40588229 | Comparative efficacy of oral nucleotide analogues for the prophylaxis of hepatitis B virus recurrence after liver transplantation: a network meta-analysis. |
| Q33766133 | Comparing methods of data synthesis: re-estimating parameters of an existing probabilistic cost-effectiveness model. |
| Q55279676 | Comparison of multiple interventions for older adults with Alzheimer disease or mild cognitive impairment: A PRISMA-compliant network meta-analysis. |
| Q38013786 | Cost utility of tumour necrosis factor-α inhibitors for rheumatoid arthritis: an application of Bayesian methods for evidence synthesis in a Markov model |
| Q45893661 | Cost-Effectiveness of Golimumab in Ankylosing Spondylitis from the UK Payer Perspective |
| Q33716902 | Cost-effectiveness of interventions for increasing the possession of functioning smoke alarms in households with pre-school children: a modelling study |
| Q38080910 | Cost-effectiveness of ticagrelor in acute coronary syndromes |
| Q37763121 | Critical appraisal of pharmacoeconomic studies comparing TNF-alpha antagonists for rheumatoid arthritis treatment |
| Q35180222 | Development of a transparent interactive decision interrogator to facilitate the decision-making process in health care. |
| Q92374843 | Different types of acupuncture and moxibustion therapy for neurogenic bladder after spinal cord injury: A systematic review and network meta-analysis study protocol |
| Q36981430 | Economic evaluations of calcineurin inhibitors in renal transplantation: a literature review |
| Q42276363 | Effect of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on cardiovascular events in patients with heart failure: a meta-analysis of randomized controlled trials |
| Q40373726 | Effectiveness and Tolerability of Different Recommended Doses of PPIs and H2RAs in GERD: Network Meta-Analysis and GRADE system |
| Q92756371 | Effectiveness and safety of steady versus intermittent high dose vitamin D supplementation for the prevention of falls and fractures among adults: a protocol for systematic review and network meta-analysis |
| Q33576871 | Effectiveness of triple therapy with direct-acting antivirals for hepatitis C genotype 1 infection: application of propensity score matching in a national HCV treatment registry |
| Q35557492 | Effects of RAS inhibitors on diabetic retinopathy: a systematic review and meta-analysis |
| Q28547354 | Efficacy and Safety of HER2-Targeted Agents for Breast Cancer with HER2-Overexpression: A Network Meta-Analysis |
| Q41521650 | Efficacy and safety of endocrine monotherapy as first-line treatment for hormone-sensitive advanced breast cancer: A network meta-analysis. |
| Q38212142 | Efficacy and safety of infliximab-biosimilar compared to other biological drugs in rheumatoid arthritis: a mixed treatment comparison |
| Q88628972 | Efficacy and safety of mechanical versus manual compression in cardiac arrest - A Bayesian network meta-analysis |
| Q30843177 | Efficacy and safety of medical therapy for low bone mineral density in patients with Crohn disease: A systematic review with network meta-analysis |
| Q49284231 | Efficacy of Lactobacillus reuteri DSM 17938 for infantile colic: Systematic review with network meta-analysis |
| Q34765596 | Efficacy of new generation antidepressants: differences seem illusory |
| Q48124426 | Evaluation of short-term effectiveness of eight targeted agents combined with chemotherapy for treating esophageal-gastric junction adenocarcinoma: A network meta-analysis. |
| Q41668847 | Factors affecting the cost-effectiveness of on-farm culture prior to the treatment of clinical mastitis in dairy cows |
| Q34915090 | Gastrointestinal adverse events of glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a systematic review and network meta-analysis |
| Q89963554 | Hydration Strategies for Preventing Contrast-Induced Acute Kidney Injury: A Systematic Review and Bayesian Network Meta-Analysis |
| Q36520655 | Impact of GLP-1 receptor agonists on major gastrointestinal disorders for type 2 diabetes mellitus: a mixed treatment comparison meta-analysis |
| Q39033236 | Improving costing methods in multicentre economic evaluation: the use of multiple imputation for unit costs. |
| Q30594247 | Incorporating data from various trial designs into a mixed treatment comparison model |
| Q30580634 | Incorporating external evidence in trial-based cost-effectiveness analyses: the use of resampling methods |
| Q43421065 | Indirect comparison between subcutaneous biologic agents in ankylosing spondylitis |
| Q44564160 | Indirect comparison of etanercept, infliximab, and adalimumab for psoriatic arthritis: mixed treatment comparison using placebo as common comparator |
| Q41413446 | Indirect comparisons of second-generation tyrosine kinase inhibitors in CML: case study using baseline population characteristics |
| Q37254814 | Integration of meta-analysis and economic decision modeling for evaluating diagnostic tests |
| Q36452604 | Is Local Infiltration Analgesia Superior to Peripheral Nerve Blockade for Pain Management After THA: A Network Meta-analysis |
| Q92280744 | Is There Something Else Beyond Cost-Effectiveness Analysis for Public Health Decision Making? |
| Q36025741 | Is primary angioplasty cost effective in the UK? Results of a comprehensive decision analysis |
| Q34573490 | Management of chronic neuropathic pain: a protocol for a multiple treatment comparison meta-analysis of randomised controlled trials |
| Q31135481 | Methods for network meta-analysis of continuous outcomes using individual patient data: a case study in acupuncture for chronic pain. |
| Q24202055 | Methotrexate monotherapy and methotrexate combination therapy with traditional and biologic disease modifying anti-rheumatic drugs for rheumatoid arthritis: A network meta-analysis |
| Q38939820 | Methotrexate monotherapy and methotrexate combination therapy with traditional and biologic disease modifying anti-rheumatic drugs for rheumatoid arthritis: A network meta-analysis. |
| Q26751187 | Methotrexate monotherapy and methotrexate combination therapy with traditional and biologic disease modifying antirheumatic drugs for rheumatoid arthritis: abridged Cochrane systematic review and network meta-analysis |
| Q28087732 | Ministernotomy or minithoracotomy for minimally invasive aortic valve replacement: a Bayesian network meta-analysis |
| Q55345522 | Missing data in trial-based cost-effectiveness analysis: An incomplete journey. |
| Q37405745 | Mixed treatment comparison meta-analysis of complex interventions: psychological interventions in coronary heart disease |
| Q36404994 | Modeling human papillomavirus and cervical cancer in the United States for analyses of screening and vaccination |
| Q40028428 | Multiparameter evidence synthesis in epidemiology and medical decision-making |
| Q52302553 | Multiple parameter evidence synthesis--a potential solution for when information on drug use and harm is in conflict. |
| Q35089776 | Multiple treatment comparison meta-analyses: a step forward into complexity. |
| Q90685817 | Network Meta-Analysis of Adjuvant Chemotherapy following Resection of Colorectal Liver Metastases |
| Q36897982 | Network Meta-Analysis of the Effectiveness of Neoadjuvant Endocrine Therapy for Postmenopausal, HR-Positive Breast Cancer |
| Q37349036 | Network Meta-Analysis of the Efficacy of Acupuncture, Alpha-blockers and Antibiotics on Chronic Prostatitis/Chronic Pelvic Pain Syndrome |
| Q30850451 | Network meta-analysis of (individual patient) time to event data alongside (aggregate) count data |
| Q21132357 | Network meta-analysis of erlotinib, gefitinib, afatinib and icotinib in patients with advanced non-small-cell lung cancer harboring EGFR mutations |
| Q33891529 | Network meta-analysis of survival data with fractional polynomials |
| Q35103135 | Network meta-analysis on prophylactic regimens against recurrent hepatitis B virus infection after liver transplantation |
| Q33600403 | Network meta-analysis on the log-hazard scale, combining count and hazard ratio statistics accounting for multi-arm trials: a tutorial |
| Q39839052 | No head-to-head trial? simulate the missing arms. |
| Q35660038 | Optimal adjuvant therapy for resected hepatocellular carcinoma: a systematic review with network meta-analysis |
| Q28087211 | Optimal drug regimens for primary biliary cirrhosis: a systematic review and network meta-analysis |
| Q92066832 | Outcomes of 4 surgical adjuvants used for internal limiting membrane peeling in macular hole surgery: a systematic review and network Meta-analysis |
| Q38744165 | Pharmacoeconomic evaluations in the treatment of actinic keratoses |
| Q33735269 | Pregabalin versus gabapentin in partial epilepsy: a meta-analysis of dose-response relationships. |
| Q39366897 | Presentational approaches used in the UK for reporting evidence synthesis using indirect and mixed treatment comparisons. |
| Q45337074 | Quality of life, resource consumption and costs of spinal cord stimulation versus conventional medical management in neuropathic pain patients with failed back surgery syndrome (PROCESS trial). |
| Q37696908 | Real role of β-blockers in regression of left ventricular mass in hypertension patients: Bayesian network meta-analysis |
| Q35851003 | Relevance of indirect comparisons in the German early benefit assessment and in comparison to HTA processes in England, France and Scotland |
| Q36868846 | Results of indirect and mixed treatment comparison of fracture efficacy for osteoporosis treatments: a meta-analysis |
| Q38288201 | Root canal centering ability of rotary cutting nickel titanium instruments: A meta-analysis |
| Q92627543 | Simultaneous, Delayed and Liver-First Hepatic Resections for Synchronous Colorectal Liver Metastases: A Systematic Review and Network Meta-Analysis |
| Q38990822 | Single-agent maintenance therapy for advanced non-small cell lung cancer (NSCLC): a systematic review and Bayesian network meta-analysis of 26 randomized controlled trials |
| Q39384575 | Strategies for Preventing Endoscopic Recurrence of Crohn's Disease 1 Year after Surgery: A Network Meta-Analysis |
| Q53828948 | Study protocol: quantitative fibronectin to help decision-making in women with symptoms of preterm labour (QUIDS) part 2, UK Prospective Cohort Study. |
| Q26768128 | Systematic Review and Network Meta-Analysis of Randomized Controlled Trials: Comparative Effectiveness and Safety of Direct-Acting Antiviral Agents for Treatment-Naive Hepatitis C Genotype 1 |
| Q35345620 | Systematic literature review and network meta-analysis comparing bone-targeted agents for the prevention of skeletal-related events in cancer patients with bone metastasis |
| Q21195844 | Systematic review and network meta-analysis of interventions for fibromyalgia: a protocol |
| Q26798301 | Systematic review and network meta-analysis: neoadjuvant chemoradiotherapy for locoregional esophageal cancer |
| Q38888227 | Systematic review with meta-analysis: comparative efficacy of biologics for induction and maintenance of mucosal healing in Crohn's disease and ulcerative colitis controlled trials |
| Q39012932 | Systematic review with meta-analysis: comparative efficacy of immunosuppressants and biologics for reducing hospitalisation and surgery in Crohn's disease and ulcerative colitis. |
| Q38311380 | Systematic review with network meta-analysis: adjuvant chemotherapy for resected colorectal liver metastases |
| Q26864932 | Systematic review with network meta-analysis: adjuvant therapy for resected biliary tract cancer |
| Q35946029 | Systematic review with network meta-analysis: statins and risk of hepatocellular carcinoma |
| Q37520856 | Systematic review, network meta-analysis and economic evaluation of biological therapy for the management of active psoriatic arthritis. |
| Q37451168 | Systematic reviews of economic evaluations: utility or futility? |
| Q38531310 | Systemic antibiotics in the treatment of aggressive periodontitis. A systematic review and a Bayesian Network meta-analysis. |
| Q36886256 | The contrast and convergence of Bayesian and frequentist statistical approaches in pharmacoeconomic analysis |
| Q37990316 | The efficacy and safety of pharmacological prophylaxis of venous thromboembolism following elective knee or hip replacement: systematic review and network meta-analysis |
| Q42672230 | The impact of using informative priors in a Bayesian cost-effectiveness analysis: an application of endovascular versus open surgical repair for abdominal aortic aneurysms in high-risk patients |
| Q33629488 | The importance of adjusting for potential confounders in Bayesian hierarchical models synthesising evidence from randomised and non-randomised studies: an application comparing treatments for abdominal aortic aneurysms |
| Q27690869 | The relative efficacy of boceprevir and telaprevir in the treatment of hepatitis C virus genotype 1. |
| Q36649196 | The relative efficacy of imatinib, dasatinib and nilotinib for newly diagnosed chronic myeloid leukemia: a systematic review and network meta-analysis |
| Q36450771 | The role of induction and adjuvant chemotherapy in combination with concurrent chemoradiotherapy for nasopharyngeal cancer: a Bayesian network meta-analysis of published randomized controlled trials |
| Q30586377 | The use of individual patient-level data (IPD) to quantify the impact of pretreatment predictors of response to treatment in chronic hepatitis B patients. |
| Q61451057 | To Use or Not to Use Opioid Analgesia for Acute Abdominal Pain Before Definitive Surgical Diagnosis? A Systematic Review and Network Meta-Analysis |
| Q27011699 | Treatments for shoulder impingement syndrome: a PRISMA systematic review and network meta-analysis |
| Q38922071 | USING EXPERT OPINION IN HEALTH TECHNOLOGY ASSESSMENT: A GUIDELINE REVIEW. |
| Q51717762 | Uncertainty and patient heterogeneity in medical decision models. |
| Q38122249 | Use of implicit and explicit bayesian methods in health technology assessment. |
| Q37259556 | Use of indirect and mixed treatment comparisons for technology assessment |
| Q36972556 | Use of mixed-treatment-comparison methods in estimating efficacy of treatments for heavy menstrual bleeding |
| Q37619002 | Using information graphics in health technology assessment: toward a structured approach |
| Q36635492 | Using value of information analysis to prioritise health research: some lessons from recent UK experience |
| Q51924377 | Validity of indirect comparisons in meta-analysis. |
| Q50939811 | Value of Information: We've Got Speed, What More Do We Need? |
Search more.